Blog

Advarra VP of Insitutional Services James Riddle discusses using virtual trial components in traditional study designs. Read more:

Advarra Director of Biosafety Daniel Eisenman reviews opportunities, risks, and risk mitigation strategies for coronavirus research. Read more:

The Revised Common Rule is here after multiple delays, exceptions, and many training sessions. As of January 20, 2020, this regulation is in full effect.

Go beyond the regulatory requirements and examine three key actions research organizations must consider before conducting planned emergency research.

What did the research community enjoy most in 2019? Read Advarra's most popular blogs from industry experts and IRB members here.

Reportable events can be tricky: according to the regulations, not every unanticipated event should be submitted to the IRB.

Uncover what the regulations say about IRB reporting requirements and how Advarra has addressed some of the undefined gray areas around noncompliance.

Understand how the new HUD guidance clarifies responsibilites of the IRB and institutions, while widening the access of small communities to HUDs.

Social media has emerged as a valuable tool for diverse stakeholders across the research community. Learn about the risks and benefits in this article.

Learn how institutions attract more studies from the the tale of two sites: one with an integrated research administration, and one without.

What do the regulations say about unanticipated device effects and IRB reporting requirements? In this blog, Advarra addresses some frustrating gray areas.

On September 5, 2019, Advarra announced its intent to acquire Forte.